Skip to main content

Table 2 Correlation between AIM2, clinical characteristics, and lab findings in CHB group

From: Expression of AIM2 is correlated with increased inflammation in chronic hepatitis B patients

  

AIM2

  
 

n

+

++

+++

x 2

p

Male

30

1(3.3 %)

8(26.7 %)

10(33.3 %)

11(36.7 %)

5.351

0.148

Age(years)

     

4.918

0.178

 20–40

30

3(10.0 %)

9(30.0 %)

7(23.3 %)

11(36.7 %)

  

 40–60

17

2(11.8 %)

1(5.9 %)

8(47.0 %)

6(35.3 %)

  

ALT

     

39.987

0.030

 ULN-2ULN

32

5(15.6 %)

7(21.9 %)

9(28.1 %)

11(34.4 %)

  

 2ULN-5ULN

15

0(0 %)

3(20.0 %)

6(40.0 %)

6(40.0 %)

  

AST

     

36.487

0.378

 ULN-2ULN

38

4(10.5 %)

9(23.7 %)

12(31.6 %)

13(34.2 %)

  

 2ULN-5ULN

9

1(11.1 %)

1(11.1 %)

3(33.3 %)

4(44.4 %)

  

eAg

     

0.049

0.825

 Positive

26

3(11.5 %)

5(19.2 %)

9(34.6 %)

9(34.6 %)

  

 Negative

21

2(9.5 %)

5(23.8 %)

6(28.6 %)

8(38.1 %)

  

HBV DNA

     

25.96

<0.001

 ≥ 105copies/mL

25

0(0 %)

0(0 %)

10(40.0 %)

15(60.0 %)

  

 < 105copies/mL

22

5(20.0 %)

10(40.0 %)

5(20.0 %)

2(8.0 %)

  
  1. CHB chronic hepatitis B, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ULN upper limits of normal